Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 8081
TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139994(US8901140, 9 | US9358227, 9)
Affinity DataIC50: 2nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139993(US8901140, 8 | US9358227, 8)
Affinity DataIC50: 2nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139989(US8901140, 2 | US9358227, 2)
Affinity DataIC50: 3nMAssay Description:The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high ex...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139992(US8901140, 7 | US9358227, 7)
Affinity DataIC50: 4nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139989(US8901140, 2 | US9358227, 2)
Affinity DataIC50: 6nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139994(US8901140, 9 | US9358227, 9)
Affinity DataIC50: 8nMAssay Description:The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high ex...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139991(US8901140, 5 | US9358227, 5)
Affinity DataIC50: 13nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139988(US8901140, 1 | US9358227, 1)
Affinity DataIC50: 22nMAssay Description:The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high ex...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139990(US8901140, 3 | US9358227, 3)
Affinity DataIC50: 36nMAssay Description:The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high ex...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139991(US8901140, 5 | US9358227, 5)
Affinity DataIC50: 45nMAssay Description:The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high ex...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139988(US8901140, 1 | US9358227, 1)
Affinity DataIC50: 48nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM139990(US8901140, 3 | US9358227, 3)
Affinity DataIC50: 59nMAssay Description:The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inh...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2017
Entry Details
US Patent